This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • The impact of collagen crosslinking on keratoplasty numbers in keratoconics

The impact of collagen crosslinking on keratoplasty numbers in keratoconics
Reviewed by Magdalena Popiela

1 October 2015 | Magdalena Popiela | EYE - Cornea, EYE - General

A question of corneal cross-linking (CXL) reducing keratoplasty numbers in keratoconics was addressed in this single centre observational study from the Oslo University Hospital – a sole provider of keratoplasties and CXL for a population of 2.8 million. Authors compared keratoplasty rates between two periods: period 1 – pre introduction of CXL (2005-2006) and period 2 – post introduction of CXL (2013-2014). The total number of keratoplasties in period 1 was 137 with 55 performed for keratoconus. In period 2 corresponding numbers were 231 and 26 respectively with the difference between the numbers of keratoconus keratoplasties in two periods being statistically significant. There were no significant differences in the age and gender distributions between both periods, but interestingly in period 2 only 3 patients were younger than 25 versus 13 in period 1. There were significantly more stage 4 keratoconus patients undergoing keratoplasty in period 2 compared to period 1. These results point to a significant reduction of keratoplasties for keratoconus between two periods, which is most likely secondary to the introduction of CXL into clinical practice. However further large longitudinal studies are needed to make definite conclusions.

Does collagen cross-linking reduce the need for keratoplasties in patients with keratoconus?
Sandvik GF, Thorsrud A, Råen M, et al.
CORNEA
2015;34(9):991-5.
Share This
Magdalena Popiela
CONTRIBUTOR
Magdalena Popiela

Royal Gwent Hospital, Cardiff, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency